← Browse by Condition
Medical Condition
b cell lymphoma
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 1
NCT05281809 Phase 2
Recruiting
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
Enrollment
30 pts
Location
United States
Sponsor
John Lister
NCT06131801
Recruiting
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
NCT06566586 Phase 2
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma
Enrollment
80 pts
Location
China
Sponsor
Chia Tai Tianqing Pharmaceutic...
NCT07369492 Phase 1
Recruiting
Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma
Enrollment
30 pts
Location
China
Sponsor
Jiangsu Topcel-KH Pharmaceutic...
NCT03787056
Recruiting
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Enrollment
410 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT06180174 Phase 1
Recruiting
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
Enrollment
24 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
NCT06484920 Phase 2
Recruiting
A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL
Enrollment
24 pts
Location
United States
Sponsor
Rita Assi